Real-world effectiveness and safety of a recombinant factor VIII Fc in patients with haemophilia A by disease severity: Pooled analysis (A-SURE/PREVENT)

被引：0
|
作者：
Holme, P. A. [1 ]
Alvarez Roman, M. T. [2 ]
Tagliaferri, A. [3 ]
Oldenburg, J. [4 ]
Halimeh, S. [5 ]
Lauer, S. [6 ]
Fusser, M. [6 ]
Gresko, E. [7 ]
Lethagen, S. [6 ,8 ]
机构：
[1] Univ Oslo, Oslo Univ Hosp, Inst Clin Med, Dept Haematol, Oslo, Norway
[2] La Paz Univ Hosp IdiPaz, Dept Haematol, Madrid, Spain
[3] Univ Hosp Parma, Reg Reference Ctr Inherited Bleeding Disorders, Parma, Italy
[4] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany
[5] erinnungszentrum Rhein Ruhr, Duisburg, Germany
[6] Sobi, Stockholm, Sweden
[7] Sobi, Basel, Switzerland
[8] Univ Copenhagen, Copenhagen, Denmark
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO099
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [21] Safety and effectiveness of recombinant factor XIII-A2 in congenital factor XIII deficiency: Real-world evidence
    Poulsen, Lone Hvitfeldt
    Kerlin, Bryce A.
    Castaman, Giancarlo
    Molinari, Angelo Claudio
    Menegatti, Marzia
    Nugent, Diane
    Dey, Sohan
    Garly, May-Lill
    Carcao, Manuel
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (02)
  • [22] Real-world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders
    Holmstrom, Margareta
    Olsson, Elsa
    Astermark, Jan
    Axelsson, Malin
    Olsson, Anna
    Myrin Westesson, Linda
    Falk, Aletta
    Szamosi, Johan
    Sennfalt, Karin
    HAEMOPHILIA, 2021, 27 (04) : E554 - E558
  • [23] Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn's Disease Patients
    Garg, Rajat
    Aggarwal, Manik
    Butler, Robert
    Achkar, Jean Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Qazi, Taha
    Rieder, Florian
    Regueiro, Miguel
    Click, Benjamin
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) : 3138 - 3147
  • [24] Effectiveness and safety of ustekinumab in patients with Crohn's disease: a real-world experience
    Mohammad, D.
    Alshahrani, A.
    Bao, Y.
    Alramdan, R.
    Rajani, A.
    Chauhan, U.
    Salena, B.
    Tse, F.
    Greenwald, E.
    Albashir, S.
    Halder, S.
    Armstrong, D.
    Marshall, J.
    Narula, N.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S426 - S426
  • [25] Real-world effectiveness and safety of deutetrabenazine in patients with chorea associated with Huntington disease
    Sung, V.
    White, A.
    Romdhani, H.
    Goldschmidt, D.
    Ayyagari, R.
    Chaijale, N.
    Yaari, A.
    Gordon, M.
    Logan, J.
    Yang, A.
    Ribalov, R.
    MOVEMENT DISORDERS, 2023, 38 : S401 - S401
  • [26] Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease Patients
    Rajat Garg
    Manik Aggarwal
    Robert Butler
    Jean Paul Achkar
    Bret Lashner
    Jessica Philpott
    Benjamin Cohen
    Taha Qazi
    Florian Rieder
    Miguel Regueiro
    Benjamin Click
    Digestive Diseases and Sciences, 2022, 67 : 3138 - 3147
  • [27] Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data
    Ash Bullement
    Samuel Thomas McMordie
    Anthony James Hatswell
    Nanxin Li
    Koo Wilson
    PharmacoEconomics - Open, 2020, 4 : 133 - 142
  • [28] Real-world effectiveness and usage of recombinant factor IX Fc: Secondary paediatric analysis from the 24-month french, prospective, non-interventional B-SURE study
    Chambost, H.
    Oudot, C.
    Genre-Volot, F.
    Wibaut, B.
    Biron-Andreani, C.
    d'Oiron, R.
    Bayart, S.
    Chamouni, P.
    Harroche, A.
    Vanderbecken, S.
    Zidi, M.
    Lauer, S.
    Palmborg, H.
    Gresko, E.
    HAEMOPHILIA, 2024, 30 : 68 - 69
  • [29] Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data
    Bullement, Ash
    McMordie, Samuel Thomas
    Hatswell, Anthony James
    Li, Nanxin
    Wilson, Koo
    PHARMACOECONOMICS-OPEN, 2020, 4 (01) : 133 - 142
  • [30] Real-world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow-up retrospective analysis
    Carcao, Manuel
    Shapiro, Amy
    Hwang, Nina
    Pipe, Steven
    Ahuja, Sanjay
    Lieuw, Ken
    Staber, Janice M.
    Belletrutti, Mark
    Sun, Haowei Linda
    Ding, Hilda
    Wang, Michael
    Price, Victoria
    Steele, MacGregor
    Tsao, Elisa
    Feng, Jing
    Al-Khateeb, Zahra
    Dumont, Jennifer
    Jain, Nisha
    HAEMOPHILIA, 2021, 27 (01) : 19 - 25
12345